Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3049653 | 0.87 | SLC18A2 (0.32) | SLC18A2 | |
| SCHEMBL3058285 | 0.84 | GAA (0.38) | SLC18A2GAAL3MBTL1 | |
| SCHEMBL3057720 | 0.79 | GAA (0.34) | SLC18A2GAAL3MBTL1 | |
| SCHEMBL21908618 | 0.78 | GAA (0.44) | SLC18A2GAAL3MBTL1 | |
| SCHEMBL21908653 | 0.77 | GAA (0.40) | SLC18A2GAAL3MBTL1 | |
| SCHEMBL3056898 | 0.77 | MAPT (0.35) | SLC18A2GAAL3MBTL1 | |
| SCHEMBL12846027 | 0.77 | GAA (0.42) | SLC18A2GAAL3MBTL1 | |
| SCHEMBL3057231 | 0.77 | GAA (0.42) | SLC18A2GAAL3MBTL1 | |
| SCHEMBL21908629 | 0.75 | GAA (0.41) | SLC18A2GAAL3MBTL1 | |
| SCHEMBL21908632 | 0.75 | GAA (0.41) | SLC18A2GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100260684-A1 | USE OF 3-ALKANOYLOXYMETHOXYCARBONYL NITROXIDE ESTERS AS OXIMETRY PROBES FOR MEASUREMENT OF OXYGEN STATUS IN TISSUES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100260684-A1 | USE OF 3-ALKANOYLOXYMETHOXYCARBONYL NITROXIDE ESTERS AS OXIMETRY PROBES FOR MEASUREMENT OF OXYGEN STATUS IN TISSUES | APEH, LPO, ALKBH3 | SLC18A2 421/4885GAA 751/4885L3MBTL1 1004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.